Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine add-on to SSRI/SNRI for treatment-resistant depression in primary care
2012-000090-23Phase 4Completed
- Sponsor
- University of Bristol
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirtazapine in treatment-resistant depression (TRD), major depressive disorder (MDD), sponsored by University of Bristol. Started Jun 2013; status: completed.
02
Drugs
mirtazapine
03
Conditions
treatment-resistant depression (TRD)major depressive disorder (MDD)
Beyond the preview
Go deeper on 2012-000090-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000090-23.